메뉴 건너뛰기




Volumn 66, Issue 3, 2008, Pages 345-351

The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACE-Is and ARBS

Author keywords

ACE inhibitors; Angiotensin receptors blockers; Atrial fibrillation; Recurrence; Renin angiotensin system

Indexed keywords

AMIODARONE; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDRALAZINE; IRBESARTAN; LOSARTAN; PERINDOPRIL; RAMIPRIL; TELMISARTAN; VALSARTAN;

EID: 49549102549     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2008.03234.x     Document Type: Review
Times cited : (65)

References (52)
  • 1
    • 0035832261 scopus 로고    scopus 로고
    • Prevalence of diagnosed atrial fibrillation in adults: National implication for rhythm management and stroke prevention: The anticoagulation and Risk Factors in Atria Fibrillation (Atria) Study
    • Go AS, Hilek M, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implication for rhythm management and stroke prevention: the anticoagulation and Risk Factors in Atria Fibrillation (Atria) Study. JAMA 2001 285 : 2370 5.
    • (2001) JAMA , vol.285 , pp. 2370-5
    • Go, A.S.1    Hilek, M.2    Phillips, K.A.3    Chang, Y.4    Henault, L.E.5    Selby, J.V.6    Singer, D.E.7
  • 4
    • 2542507510 scopus 로고    scopus 로고
    • Characterization of different subset of atrial fibrillation in general practice in France: The ALFA study
    • Levy S, Maarek M, Coumel P, Guize L, Lekieffre J, Medvedowsky JL, Sebaoun A. Characterization of different subset of atrial fibrillation in general practice in France: the ALFA study. Circulation 1999 99 : 3028 35.
    • (1999) Circulation , vol.99 , pp. 3028-35
    • Levy, S.1    Maarek, M.2    Coumel, P.3    Guize, L.4    Lekieffre, J.5    Medvedowsky, J.L.6    Sebaoun, A.7
  • 5
    • 0002848836 scopus 로고
    • Tachycardia-induced tachycardia: A mechanism of initiation of atrial fibrillation
    • In: eds. Di Marco, J.P., Pristowsky, E.N. Armonk, NY: Futura
    • Pristowsky EN. Tachycardia-induced tachycardia: a mechanism of initiation of atrial fibrillation. In : Atrial Arrhythmias: State of Art, eds Di Marco JP, Pristowsky EN. Armonk, NY : Futura, 1995.
    • (1995) Atrial Arrhythmias: State of Art
    • Pristowsky, E.N.1
  • 7
    • 0028244264 scopus 로고
    • Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials
    • Atrial Fibrillation Investigators.
    • Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994 154 : 1449 57.
    • (1994) Arch Intern Med , vol.154 , pp. 1449-57
  • 8
    • 0036797537 scopus 로고    scopus 로고
    • A population-based study of the long-term risk associated with atrial fibrillation: 20 year follow-up of the Renfrew/Paisley study
    • Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risk associated with atrial fibrillation: 20 year follow-up of the Renfrew/Paisley study. Am J Med 2002 113 : 359 64.
    • (2002) Am J Med , vol.113 , pp. 359-64
    • Stewart, S.1    Hart, C.L.2    Hole, D.J.3    McMurray, J.J.4
  • 9
    • 0029029056 scopus 로고
    • The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the Manitoba Follow-Up Study
    • Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 1995 98 : 476 84.
    • (1995) Am J Med , vol.98 , pp. 476-84
    • Krahn, A.D.1    Manfreda, J.2    Tate, R.B.3    Mathewson, F.A.4    Cuddy, T.E.5
  • 11
    • 34447280098 scopus 로고    scopus 로고
    • Comparison of rate versus rhythm control for atrial fibrillation in patients with left ventricular dysfunction (from the AFFIRM Study)
    • Freudenberger RS, Wilson AC, Kostis JB. Comparison of rate versus rhythm control for atrial fibrillation in patients with left ventricular dysfunction (from the AFFIRM Study). Am J. Cardiol 2007 100 : 247 52.
    • (2007) Am J. Cardiol , vol.100 , pp. 247-52
    • Freudenberger, R.S.1    Wilson, A.C.2    Kostis, J.B.3
  • 12
    • 0034715973 scopus 로고    scopus 로고
    • Rhythm or rate control in atrial fibrillation - Pharmacologic Intervention in Atrial Fibrillation (PIAF): A randomized trial
    • Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation - Pharmacologic Intervention in Atrial Fibrillation (PIAF): a randomized trial. Lancet 2000 356 : 1789 94.
    • (2000) Lancet , vol.356 , pp. 1789-94
    • Hohnloser, S.H.1    Kuck, K.H.2    Lilienthal, J.3
  • 13
    • 0025675680 scopus 로고
    • Remodelling of the rat right and left ventricles in experimental hypertension
    • Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT. Remodelling of the rat right and left ventricles in experimental hypertension. Circ Res 1990 67 : 1355 64.
    • (1990) Circ Res , vol.67 , pp. 1355-64
    • Brilla, C.G.1    Pick, R.2    Tan, L.B.3    Janicki, J.S.4    Weber, K.T.5
  • 14
    • 85047680324 scopus 로고
    • Myocardial fibrosis: Functional significance and regulatory factors
    • Weber KT, Brilla CG, Janicki JS. Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res 1993 27 : 341 8.
    • (1993) Cardiovasc Res , vol.27 , pp. 341-8
    • Weber, K.T.1    Brilla, C.G.2    Janicki, J.S.3
  • 16
    • 0002807288 scopus 로고    scopus 로고
    • Cardiac anatomy and pathologic correlates of atrial fibrillation
    • In: edn, eds. Falk, R.H., Podrid, P.J. Philadelphia, PA: Lippincott-Raven
    • Lie JT, Falk RH, James TN. Cardiac anatomy and pathologic correlates of atrial fibrillation. In : Atrial Fibrillation: Mechanisms and Management, 2nd edn, eds Falk RH, Podrid PJ. Philadelphia, PA : Lippincott-Raven, 1997 23 52.
    • (1997) Atrial Fibrillation: Mechanisms and Management, 2nd , pp. 23-52
    • Lie, J.T.1    Falk, R.H.2    James, T.N.3
  • 19
    • 0035923479 scopus 로고    scopus 로고
    • Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure
    • Li D, Shinagawa K, Pang L, Leung TK, Cardin S, Wang Z, Nattel S. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 2001 104 : 2608 14.
    • (2001) Circulation , vol.104 , pp. 2608-14
    • Li, D.1    Shinagawa, K.2    Pang, L.3    Leung, T.K.4    Cardin, S.5    Wang, Z.6    Nattel, S.7
  • 20
    • 0028275578 scopus 로고
    • Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to angiotensin II and aldosterone
    • Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol 1994 26 : 809 20.
    • (1994) J Mol Cell Cardiol , vol.26 , pp. 809-20
    • Brilla, C.G.1    Zhou, G.2    Matsubara, L.3    Weber, K.T.4
  • 21
    • 0027182438 scopus 로고
    • Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocyte and hyperplasia of cardiac fibroblasts: Critical role of the AT1 receptor subtype
    • Sadoshima J, Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocyte and hyperplasia of cardiac fibroblasts: critical role of the AT1 receptor subtype. Circ Res 1993 73 : 413 23.
    • (1993) Circ Res , vol.73 , pp. 413-23
    • Sadoshima, J.1    Izumo, S.2
  • 23
    • 0242636836 scopus 로고    scopus 로고
    • Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease
    • Boldt A, Wetzel U, Weigl J, Garbade J, Lauschke J, Hindricks G, Kottkamp H, Gummert JF, Dhein S. Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease. J Am Coll Cardiol 2003 42 : 1785 92.
    • (2003) J Am Coll Cardiol , vol.42 , pp. 1785-92
    • Boldt, A.1    Wetzel, U.2    Weigl, J.3    Garbade, J.4    Lauschke, J.5    Hindricks, G.6    Kottkamp, H.7    Gummert, J.F.8    Dhein, S.9
  • 24
    • 0034687120 scopus 로고    scopus 로고
    • Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation
    • Everett THIV, Li H, Mangrum JM, McRury ID, Mitchell MA, Redick JA, Haines DE. Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation. Circulation 2000 102 : 1454 60.
    • (2000) Circulation , vol.102 , pp. 1454-60
    • Thiv, E.1    Li, H.2    Mangrum, J.M.3    McRury, I.D.4    Mitchell, M.A.5    Redick, J.A.6    Haines, D.E.7
  • 25
    • 0034612362 scopus 로고    scopus 로고
    • Angiotensin II antagonist prevents electrical remodelling in atrial fibrillation
    • Nakashima H, Kumagai K, Urata H, Gondo N, Ideishi M, Arakawa K. Angiotensin II antagonist prevents electrical remodelling in atrial fibrillation. Circulation 2000 101 : 2612 7.
    • (2000) Circulation , vol.101 , pp. 2612-7
    • Nakashima, H.1    Kumagai, K.2    Urata, H.3    Gondo, N.4    Ideishi, M.5    Arakawa, K.6
  • 26
    • 33645735529 scopus 로고    scopus 로고
    • Angiotensin II potentiates the slow component of delayed rectifier K+ current via the AT1 receptor in guinea pig atrial myocytes
    • Zankov DP, Omatsu-Kanbe M, Isono T, Toyoda F, Ding WG, Matsuura H, Horie M. Angiotensin II potentiates the slow component of delayed rectifier K+ current via the AT1 receptor in guinea pig atrial myocytes. Circulation 2006 113 : 1278 86.
    • (2006) Circulation , vol.113 , pp. 1278-86
    • Zankov, D.P.1    Omatsu-Kanbe, M.2    Isono, T.3    Toyoda, F.4    Ding, W.G.5    Matsuura, H.6    Horie, M.7
  • 28
    • 0346034542 scopus 로고    scopus 로고
    • Angiotensin-converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation
    • Pt 2
    • Gensini F, Padeletti L, Fatini C, Sticchi E, Gensini GF, Michelucci A. Angiotensin-converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation. Pacing Clin Electrophysiol 2003 26 (1 Pt 2 295 8.
    • (2003) Pacing Clin Electrophysiol , vol.26 , Issue.1 , pp. 295-8
    • Gensini, F.1    Padeletti, L.2    Fatini, C.3    Sticchi, E.4    Gensini, G.F.5    Michelucci, A.6
  • 29
    • 0036247120 scopus 로고    scopus 로고
    • Relation between angiotensin converting enzyme II genotype and atrial fibrillation in Japanese patients with hypertrophic cardiomyopathy
    • Ogimoto A, Hamada M, Nakura J, Miki T, Hiwada K. Relation between angiotensin converting enzyme II genotype and atrial fibrillation in Japanese patients with hypertrophic cardiomyopathy. J Hum Genet 2002 47 : 184 9.
    • (2002) J Hum Genet , vol.47 , pp. 184-9
    • Ogimoto, A.1    Hamada, M.2    Nakura, J.3    Miki, T.4    Hiwada, K.5
  • 30
    • 34249738442 scopus 로고    scopus 로고
    • ACE I/D polymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fibrillation
    • Darbar D, Motsinger A, Ritchie MD, Gainer JV, Roden DM. ACE I/D polymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fibrillation. Heart Rhythm 2007 4 : 743 9.
    • (2007) Heart Rhythm , vol.4 , pp. 743-9
    • Darbar, D.1    Motsinger, A.2    Ritchie, M.D.3    Gainer, J.V.4    Roden, D.M.5
  • 31
    • 0031686381 scopus 로고    scopus 로고
    • Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials
    • Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. J Am Coll Cardiol 1998 32 : 695 703.
    • (1998) J Am Coll Cardiol , vol.32 , pp. 695-703
    • Dries, D.L.1    Exner, D.V.2    Gersh, B.J.3    Domanski, M.J.4    Waclawiw, M.A.5    Stevenson, L.W.6
  • 32
    • 0038649984 scopus 로고    scopus 로고
    • Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: Insight from the Studies of Left Ventricular Dysfunction (SOLVD) Trials
    • Vermes E, Tardif JC, Bourassa MG, Racine N, Levesque S, White M, Guerra PG, Ducharme A. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies of Left Ventricular Dysfunction (SOLVD) Trials. Circulation 2003 107 : 2926 31.
    • (2003) Circulation , vol.107 , pp. 2926-31
    • Vermes, E.1    Tardif, J.C.2    Bourassa, M.G.3    Racine, N.4    Levesque, S.5    White, M.6    Guerra, P.G.7    Ducharme, A.8
  • 33
    • 0033609470 scopus 로고    scopus 로고
    • Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction
    • Pedersen OD, Bagger H, Kober L, Torp-Pedersen C. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation 1999 100 : 376 38.
    • (1999) Circulation , vol.100 , pp. 376-38
    • Pedersen, O.D.1    Bagger, H.2    Kober, L.3    Torp-Pedersen, C.4
  • 35
    • 0033589756 scopus 로고    scopus 로고
    • Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
    • Hansson L, Lindholm LH, Ekbom T, Dahlöf B, Lanke J, Scherstén B, Wester PO, Hedner T, de Faire U. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 1999 20 : 1751 6.
    • (1999) Lancet , vol.20 , pp. 1751-6
    • Hansson, L.1    Lindholm, L.H.2    Ekbom, T.3    Dahlöf, B.4    Lanke, J.5    Scherstén, B.6    Wester, P.O.7    Hedner, T.8    De Faire, U.9
  • 38
    • 17844369714 scopus 로고    scopus 로고
    • Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT)
    • Val-HeFT Investigators
    • Maggioni AP, Latini R, Peter E, Carson PE, Singh SN, Barlera S, Glazer R, Masson S, Cerè E, Tognoni G, Cohn JN Val-HeFT Investigators. Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT). Am Heart J 2005 149 : 548 5.
    • (2005) Am Heart J , vol.149 , pp. 548-5
    • Maggioni, A.P.1    Latini, R.2    Peter, E.3    Carson, P.E.4    Singh, S.N.5    Barlera, S.6    Glazer, R.7    Masson, S.8    Cerè, E.9    Tognoni, G.10    Cohn, J.N.11
  • 42
    • 33748087086 scopus 로고    scopus 로고
    • Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation
    • Yin Y, Dalal D, Liu Z, Wu J, Liu D, Lan X, Dai Y, Su L, Ling Z, She Q, Luo K, Woo K, Dong J. Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation. Eur Heart J 2006 27 : 1841 7.
    • (2006) Eur Heart J , vol.27 , pp. 1841-7
    • Yin, Y.1    Dalal, D.2    Liu, Z.3    Wu, J.4    Liu, D.5    Lan, X.6    Dai, Y.7    Su, L.8    Ling, Z.9    She, Q.10    Luo, K.11    Woo, K.12    Dong, J.13
  • 44
    • 10744221998 scopus 로고    scopus 로고
    • Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-lasting persistent atrial fibrillation: Results of a prospective and controlled study
    • Ueng KC, Tsai TP, Yu WC, Tsai CF, Lin MC, Chan KC, Chen CY, Wu DJ, Lin CS, Chen SA. Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-lasting persistent atrial fibrillation: results of a prospective and controlled study. Eur Heart J 2003 24 : 2090 8.
    • (2003) Eur Heart J , vol.24 , pp. 2090-8
    • Ueng, K.C.1    Tsai, T.P.2    Yu, W.C.3    Tsai, C.F.4    Lin, M.C.5    Chan, K.C.6    Chen, C.Y.7    Wu, D.J.8    Lin, C.S.9    Chen, S.A.10
  • 46
    • 29744454333 scopus 로고    scopus 로고
    • The impact of suppressing the renin-angiotensin system on atrial fibrillation
    • Kalus JS, Coleman CI, White CM. The impact of suppressing the renin-angiotensin system on atrial fibrillation. J Clin Pharmacol 2006 46 : 21 8.
    • (2006) J Clin Pharmacol , vol.46 , pp. 21-8
    • Kalus, J.S.1    Coleman, C.I.2    White, C.M.3
  • 47
    • 33746257148 scopus 로고    scopus 로고
    • Meta-analysis: Inhibition of renin-angiotensin system prevents new-onset atrial fibrillation
    • Anand K, Mooss AN, Hee TT, Mohiuddin SM. Meta-analysis: inhibition of renin-angiotensin system prevents new-onset atrial fibrillation. Am Heart J 2006 152 : 217 22.
    • (2006) Am Heart J , vol.152 , pp. 217-22
    • Anand, K.1    Mooss, A.N.2    Hee, T.T.3    Mohiuddin, S.M.4
  • 49
    • 3142740224 scopus 로고    scopus 로고
    • Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients
    • ONTARGET/TRASCEND Investigators
    • Teo K, Yusuf S, Seight P, Anderson C, Mookadam F, Ramos B, Hilbrich L, Pogue J, Schumacher H ONTARGET/TRASCEND Investigators. Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials. Am Heart J 2004 148 : 52 61.
    • (2004) Am Heart J , vol.148 , pp. 52-61
    • Teo, K.1    Yusuf, S.2    Seight, P.3    Anderson, C.4    Mookadam, F.5    Ramos, B.6    Hilbrich, L.7    Pogue, J.8    Schumacher, H.9
  • 50
    • 42049107348 scopus 로고    scopus 로고
    • The ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events
    • ONTARGET Investigators
    • ONTARGET Investigators, Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C. The ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008 358 : 1547 59.
    • (2008) N Engl J Med , vol.358 , pp. 1547-59
    • Yusuf, S.1    Teo, K.K.2    Pogue, J.3    Dyal, L.4    Copland, I.5    Schumacher, H.6    Dagenais, G.7    Sleight, P.8    Anderson, C.9
  • 52
    • 33744492323 scopus 로고    scopus 로고
    • Rationale and design of the GISSI-Atrial Fibrillation Trial: A randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence
    • GISSI-AF Investigators
    • Disertori M, Latini R, Maggioni AP, Delise P, Di Pasquale G, Franzosi MG, Staszewsky L, Tognoni G GISSI-AF Investigators. Rationale and design of the GISSI-Atrial Fibrillation Trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence. J Cardiovasc Med (Hagerstown) 2006 7 : 29 38.
    • (2006) J Cardiovasc Med (Hagerstown) , vol.7 , pp. 29-38
    • Disertori, M.1    Latini, R.2    Maggioni, A.P.3    Delise, P.4    Di Pasquale, G.5    Franzosi, M.G.6    Staszewsky, L.7    Tognoni, G.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.